These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 6787722

  • 41. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter.
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [Abstract] [Full Text] [Related]

  • 42. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982 Mar; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 43. Alveolar macrophage gold retention in rheumatoid arthritis.
    Garcia JG, Munim A, Nugent KM, Bishop M, Hoie-Garcia P, Parhami N, Keogh BA.
    J Rheumatol; 1987 Jun; 14(3):435-8. PubMed ID: 3114483
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
    Halla JT, Hardin JG, Linn JE.
    Arthritis Rheum; 1977 Jun; 20(6):1188-91. PubMed ID: 409414
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P, Menard H, Thompson J, Harth M, Beaudet F.
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [Abstract] [Full Text] [Related]

  • 50. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 51. Class specific rheumatoid factors in rheumatoid arthritis: response to chrysotherapy and relationship to disease activity.
    Rudge SR, Pound JD, Bossingham DH, Powell RJ.
    J Rheumatol; 1985 Jun 15; 12(3):432-6. PubMed ID: 3930719
    [Abstract] [Full Text] [Related]

  • 52. Pulmonary gold toxicity.
    Morley TF, Komansky HJ, Adelizzi RA, Giudice JC.
    Eur J Respir Dis; 1984 Nov 15; 65(8):627-32. PubMed ID: 6440806
    [Abstract] [Full Text] [Related]

  • 53. Pulmonary damage associated with gold therapy. A report of two cases.
    Terho EO, Torkko M, Valta R.
    Scand J Respir Dis; 1979 Dec 15; 60(6):345-9. PubMed ID: 120005
    [Abstract] [Full Text] [Related]

  • 54. [Gold treatment of rheumatoid arthritis].
    Wagner H, Wirth W.
    Z Rheumatol; 1978 Dec 15; 37(1-2):4-11. PubMed ID: 415451
    [Abstract] [Full Text] [Related]

  • 55. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J, Davis P, Owen ET.
    J Rheumatol; 1983 Feb 15; 10(1):121-3. PubMed ID: 6405032
    [Abstract] [Full Text] [Related]

  • 56. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP.
    Can Med Assoc J; 1980 Feb 23; 122(4):405-15. PubMed ID: 6768438
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.